Identifying patients for clinical trials is challenging in many diseases due to a lack of clear diagnostic pathways and a limited understanding of the disease. For approved therapies, failure to identify the appropriate target population results in missed opportunities for patients who can benefit from these therapies.
Graticule Patient Finder offers solutions to build and deploy screening systems at points of care to identify and recruit patients for clinical trials and provide patients with access to beneficial treatments.
Key features of the Graticule Patient Finder
- Last-mile engagement with health systems for integration into clinical workflow
- Uses elements of patient journeys derived from real-world datasets to provide customizable solutions to address business needs
- Augments data to enhance visibility into a larger real-world patient population
Challenges with patient identification
Patient identification and recruitment for clinical trials can be time-consuming and resource-intensive. Trials for rare diseases add to the burden as a large population of rare disease patients are undiagnosed due to a lack of clear diagnostic pathways and a limited understanding of the disease. For marketed drugs and therapies, failure to identify the appropriate target population leads to lower utilization rates resulting in missed opportunities for patients who can benefit from these therapies. Without adequate access to RWD patient data, life sciences teams often face difficulty in developing effective algorithms and tools.
The solution is Graticule Patient Finder
Graticule Patient Finder offers solutions to build and deploy screening systems at points of care to identify and recruit patients for clinical trials and provide patients with access to beneficial treatments. The Graticule process includes a combination of machine learning training and expert clinical guidance with access to large volumes of real-world datasets beyond EHR and claims to develop algorithms, screening processes, and workflows.
Benefits
| Efficient and accelerated patient recruitment | Improved access to care |
 |  |